Crispr Therapeutics AG (1CG) Revenue

22 Followers

Crispr Therapeutics AG Revenue

Crispr Therapeutics AG had a revenue of 10.18M in the quarter ending Jun 30, 2026, with 598.29%. This bring the company's revenue in the last twelve months to 13.39M, Decreased 226.40%. In the fiscal year ending Dec 31, 2025, Crispr Therapeutics AG had annual revenue of 3.51M with -89.97% growth.

Revenue (ttm)

13.39M

Revenue Growth

-67.70%

P/S Ratio

1229.66

Revenue/Employee

€8,931

Employees

393

Market Cap

€4.32B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	3.51M	-31.49M	-89.97%
Dec 31, 2024	35.00M	-335.00M	-90.54%
Dec 31, 2023	370.00M	369.56M	+84,762.39%
Dec 31, 2022	436.00K	-912.64M	-99.95%
Dec 31, 2021	913.08M	912.36M	+126,893.18%
Dec 31, 2020	719.00K	-288.87M	-99.75%
Dec 31, 2019	289.59M	286.47M	+9,169.85%
Dec 31, 2018	3.12M	-37.87M	-92.38%
Dec 31, 2017	41.00M	―	―